MSL Insights webinar | Emerging KOLs: Engaging Tomorrow's KOLs Today Register

COVID-19: Heart Failure

The risk of respiratory implications in COVID-19 patients is well known, but recent research shows that there is also increasing evidence that COVID-19 can cause cardiovascular complications, including heart failure, which can be a significant contributor to the mortality associated with this disease. Data has shown that the mortality rate is four times higher for patients with a history of cardiovascular disease. In this week's TTL, we review global experts and rising stars with research activities related to heart failure and COVID-19.

Read more

COVID-19: Non-Small Cell Lung Cancer

The global COVID-19 pandemic is impacting every aspect of how oncology teams operate worldwide and may have a substantial impact on cancer patients, including people with non-small cell lung cancer (NSCLC). Further, given the respiratory effects of COVID-19, patients with NSCLC and with already affected lungs are at higher risk of either direct or indirect complications from COVID-19. In this week’s TTL, we review global experts and rising stars with research activities related to NSCLC and COVID-19.

Read more

COVID-19: Type 2 Diabetes

Not only are respiratory diseases increasing the risk of developing a severe course of COVID-19, experts believe diabetes, especially type 2 diabetes, increases the risk of more serious complications in some COVID-19 patients. In a recent study, the COVID-19 mortality rate was noted to be up to 50 percent higher in people with diabetes, particularly elderly type 2 diabetes patients. In this week’s TTL, we review global experts and rising stars with research activities related to type 2 diabetes and COVID-19.

Read more

Gauging Social Media Influence - A Framework for Medical Affairs

Let’s talk about social media! This position paper by Monocl’s VP of Global Medical Strategy gets us started by providing a perspective on why medical affairs professionals need to understand and engage with experts who leverage social media.

Read more

COVID-19: ILD and IPF

Interstitial lung disease (ILD) is an umbrella term for a group of conditions that are characterized by scarring in the lung, such as idiopathic pulmonary fibrosis (IPF). As stated in last week’s TTL, people who have underlying medical issues may be at higher risk for serious illness from COVID-19, including asthma or COPD, but also people suffering from ILD or IPF. In this week’s TTL, we review global experts and rising stars with ILD, IPF and COVID-19 related research.

Read more

Repurposing Drugs to Fight SARS-CoV-2, Additional Drugs Undergoing Clinical Trials – Wrap Up

This week we wrap up our series about repurposing drugs to fight COVID-19 with a brief overview of other drugs that are currently undergoing clinical trials. But that’s not all: we queried Monocl Professional to identify leading academic experts who have significant experience working with these drugs.

Read more